COMPLETED

Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment

Conditions

Social Anxiety Disorder Specific Phobia Separation Anxiety Disorder Panic Disorder Agoraphobia Obsessive-Compulsive Disorder

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The collection of patient self-report and diagnostic data will allow us to examine the efficacy of the treatment delivered in the McLean Anxiety Mastery Program. Using data gathered through routine clinical care, the investigators seek to explore whether patients in treatment show improvements from admission to discharge, compared to patients on the waitlist, and whether these gains are maintained three months post-discharge. The following are included as examples of some of the study's hypotheses.

Official Title

Building an Outcomes Assessment Infrastructure to Assess Youth in the McLean Anxiety Mastery Program at McLean Hospital

Quick Facts

Study Start:2014-10

Study Completion:2024-11

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:COMPLETED

Study ID

NCT02305537

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:6 Years to 19 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:CHILD, ADULT

Inclusion Criteria	Exclusion Criteria
* All youth who are eligible to participate in the McLean Anxiety Mastery Program will be invited to participate in the research study. * Eligibility criteria for the McLean Anxiety Mastery Program include: * children and adolescents who are between the ages of 6 and 19 and * who present with at least one of the following disorders: * Separation Anxiety Disorder, * Social Anxiety Disorder, * Panic Disorder, * Agoraphobia, * Specific Phobia(s), and * OCD. * Interested and eligible patients and their caregivers should complete and submit an application (https://www.mcleanhospital.org/sites/default/files/2021-07/MAMP-Application-07032021\_0.pdf) to begin the phone screen process.	* Patients ineligible for the treatment program, and therefore the study, include those who have engaged in substance abuse during the six weeks prior to the first evaluation (i.e., waitlist or admission) the phone screening, * those who report that they are unwilling to refrain from self-injurious behaviors during the waitlist and treatment periods, * those who are experiencing active symptoms of psychosis, * those who exhibit severe behavioral disinhibition or aggression, and * those who express an intent and/or plan to commit suicide or homicide at the time of their first evaluation the initial phone screening. * Patients must be fluent in English to participate in the program because all off-grounds exposure groups will be conducted in English (whenever possible, however, translation services will be provided for patients whose parents are not fluent in English).

Inclusion Criteria

Exclusion Criteria

* All youth who are eligible to participate in the McLean Anxiety Mastery Program will be invited to participate in the research study.
* Eligibility criteria for the McLean Anxiety Mastery Program include:
* children and adolescents who are between the ages of 6 and 19 and
* who present with at least one of the following disorders:
* Separation Anxiety Disorder,
* Social Anxiety Disorder,
* Panic Disorder,
* Agoraphobia,
* Specific Phobia(s), and
* OCD.
* Interested and eligible patients and their caregivers should complete and submit an application (https://www.mcleanhospital.org/sites/default/files/2021-07/MAMP-Application-07032021\_0.pdf) to begin the phone screen process.

* Patients ineligible for the treatment program, and therefore the study, include those who have engaged in substance abuse during the six weeks prior to the first evaluation (i.e., waitlist or admission) the phone screening,
* those who report that they are unwilling to refrain from self-injurious behaviors during the waitlist and treatment periods,
* those who are experiencing active symptoms of psychosis,
* those who exhibit severe behavioral disinhibition or aggression, and
* those who express an intent and/or plan to commit suicide or homicide at the time of their first evaluation the initial phone screening.
* Patients must be fluent in English to participate in the program because all off-grounds exposure groups will be conducted in English (whenever possible, however, translation services will be provided for patients whose parents are not fluent in English).

Contacts and Locations

Principal Investigator

Jacqueline Sperling, Ph.D.

PRINCIPAL_INVESTIGATOR

Mclean Hospital

Study Locations (Sites)

McLean Hospital

Cambridge, Massachusetts, 02138

United States

Collaborators and Investigators

Sponsor: Mclean Hospital

Jacqueline Sperling, Ph.D., PRINCIPAL_INVESTIGATOR, Mclean Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2014-10

Study Completion Date2024-11

Study Record Updates

Study Start Date2014-10

Study Completion Date2024-11

Terms related to this study

Additional Relevant MeSH Terms

Social Anxiety Disorder
Specific Phobia
Separation Anxiety Disorder
Panic Disorder
Agoraphobia
Obsessive-Compulsive Disorder